Zacks Research Issues Negative Outlook for Chemours Earnings

The Chemours Company (NYSE:CC - Free Report) - Stock analysts at Zacks Research lowered their Q4 2025 earnings per share estimates for shares of Chemours in a report issued on Wednesday, July 9th. Zacks Research analyst R. Department now expects that the specialty chemicals company will earn $0.30 per share for the quarter, down from their previous forecast of $0.34. The consensus estimate for Chemours' current full-year earnings is $2.03 per share.

Several other analysts have also recently commented on CC. Royal Bank Of Canada lifted their price objective on shares of Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a research note on Thursday, July 3rd. The Goldman Sachs Group decreased their target price on shares of Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Morgan Stanley lowered their price target on shares of Chemours from $22.00 to $15.00 and set an "equal weight" rating on the stock in a report on Monday, May 12th. UBS Group decreased their price objective on Chemours from $18.00 to $17.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Finally, Barclays lowered their target price on Chemours from $16.00 to $13.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 28th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Chemours has an average rating of "Hold" and an average target price of $17.33.

Chemours Stock Performance

Shares of Chemours stock traded down $0.24 on Friday, reaching $13.81. 3,892,089 shares of the stock were exchanged, compared to its average volume of 2,537,633. The business has a 50 day moving average price of $11.38 and a two-hundred day moving average price of $13.96. The firm has a market capitalization of $2.07 billion, a price-to-earnings ratio of 69.05 and a beta of 1.65. Chemours has a twelve month low of $9.13 and a twelve month high of $25.54. The company has a quick ratio of 0.83, a current ratio of 1.75 and a debt-to-equity ratio of 7.01.

Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06). The firm had revenue of $1.37 billion for the quarter, compared to analysts' expectations of $1.36 billion. Chemours had a net margin of 0.54% and a return on equity of 23.82%. The firm's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.32 EPS.

Institutional Investors Weigh In On Chemours

A number of large investors have recently modified their holdings of the business. FNY Investment Advisers LLC acquired a new position in Chemours during the first quarter worth $27,000. UMB Bank n.a. boosted its position in shares of Chemours by 73.9% during the 1st quarter. UMB Bank n.a. now owns 2,231 shares of the specialty chemicals company's stock valued at $30,000 after acquiring an additional 948 shares during the last quarter. Quadrant Capital Group LLC boosted its position in shares of Chemours by 100.4% during the 4th quarter. Quadrant Capital Group LLC now owns 2,234 shares of the specialty chemicals company's stock valued at $38,000 after acquiring an additional 1,119 shares during the last quarter. Farther Finance Advisors LLC grew its holdings in shares of Chemours by 170.7% in the first quarter. Farther Finance Advisors LLC now owns 2,290 shares of the specialty chemicals company's stock valued at $30,000 after purchasing an additional 1,444 shares during the period. Finally, SouthState Corp acquired a new stake in Chemours during the first quarter worth about $34,000. Hedge funds and other institutional investors own 76.26% of the company's stock.

Insider Activity

In other news, CFO Shane Hostetter bought 4,450 shares of Chemours stock in a transaction on Monday, May 19th. The stock was acquired at an average price of $11.28 per share, with a total value of $50,196.00. Following the completion of the acquisition, the chief financial officer directly owned 59,694 shares of the company's stock, valued at $673,348.32. The trade was a 8.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Damian Gumpel bought 7,822 shares of the firm's stock in a transaction dated Tuesday, June 3rd. The stock was purchased at an average price of $9.95 per share, for a total transaction of $77,828.90. Following the transaction, the insider owned 131,701 shares of the company's stock, valued at approximately $1,310,424.95. This represents a 6.31% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 25,672 shares of company stock worth $251,573. 0.47% of the stock is currently owned by insiders.

Chemours Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, June 16th. Investors of record on Monday, May 19th were paid a $0.0875 dividend. This represents a yield of 3.17%. The ex-dividend date of this dividend was Friday, May 16th. Chemours's dividend payout ratio is presently 175.00%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.